Accrual to cancer clinical trials in the era of molecular medicine.


Enrollment of patients in a clinical trial is difficult as a result of a host of well-documented barriers. In the field of oncology, molecularly targeted treatments have demonstrated considerable therapeutic promise. At the same time, clinical testing of these targeted agents has introduced new complexities in the decision-making process by patients or… (More)
DOI: 10.1126/scitranslmed.3001712


  • Blog articles referencing this paper

  • Presentations referencing similar topics